Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Rheuminations: Road to Success in Medicine May Be Paved with Failure

Simon M. Helfgott, MD  |  Issue: February 2014  |  February 1, 2014

Around this time, J. Robin Warren, MBBS, a clinical pathologist in Perth, Australia, developed an interest in studying these newly available gastric biopsies. He was struck by the observation that he could find bacteria growing in the biopsies that showed chronic active gastritis or ulcer formation, but not in normal gastric specimens. He wondered whether these unknown microorganisms might be causing the ulcers. However, there were several problems with this theory, the first being that the highly acidic milieu of the stomach provided a hostile environment for any microbial growth. Second, the accepted dogma of ulcer causation supported the pivotal roles of stress, smoking, and NSAID use. Infections causing ulcers? How preposterous! Unperturbed, Dr. Warren enlisted the help of a gastroenterology fellow working at his hospital, Barry Marshall, DSc.

Dr. Marshall was in his final year of training and was searching for a research project that would keep him busy for the remaining few months of his training. When Warren offered him the role of endoscopist, he was delighted to sign on. They studied 100 consecutive patients with abdominal pain and suspected ulcers and found bacteria in 55 of the 57 specimens obtained from patients with ulcers.4 Yet, despite their best efforts, they could not identify the curiously shaped curved bacillus because it did not seem to grow in culture. They were frustrated by their lack of progress.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

As fate would have it, a work stoppage provided a lucky break. Over the Easter holiday break, their hospital’s microbiology laboratory was closed for five days, and this prolonged incubation time allowed the cultures to fully mature. The bacillus was identified as Helicobacter pylori. Yet this observation did not prove causation. Nonetheless, they submitted their study to the Lancet, but the editor had difficulty finding reviewers who believed their results. Most of the experts in the field of peptic ulcer disease either ridiculed their paper or dismissed their hypothesis as being a very silly idea. Sound familiar?

Drs. Marshall and Warren clung to their beliefs about H. pylori. After all, they believed that the first two of Robert Koch’s postulates had been fulfilled. First, the microorganism was abundantly present in those with disease and not in healthy individuals; second, it had been grown in pure culture.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

To fulfill Koch’s third postulate, they would have to demonstrate that the bacteria would cause disease when introduced into a healthy organism. But there was no available animal model of the disease to study. Following in the footsteps of Marie Curie, who irradiated herself, and John Hunter, whose self-infection with syphilis and gonorrhea may have been fatal, Dr. Marshall settled the issue by drinking a liquid suspension of H. pylori that was cultured from a patient’s gastric biopsy. A few days later, he developed severe abdominal bloating, bad breath, nausea, and vomiting. Endoscopy and biopsy confirmed the presence of gastritis and H. pylori.

Page: 1 2 3 4 5 6 7 | Single Page
Share: 

Filed under:Career DevelopmentEducation & TrainingOpinionProfessional TopicsResearch RheumRheuminationsSpeak Out Rheum Tagged with:anti-inflammatorydiscoveryHelfgottHistoryResearchrheumatologist

Related Articles

    The 2020 ACR Awards of Distinction & Masters Class

    November 12, 2020

    Presidential Gold Medal The highest award the ACR can bestow, the Presidential Gold Medal is awarded in recognition of outstanding achievements in rheumatology over an entire career. This year’s award went to James O’Dell, MD, the Stokes-Shackleford Professor of Internal Medicine, vice chair of internal medicine and chief of the Division of Rheumatology at the…

    A New Pain PILL: Lending a Personal Approach to Personalized Medicine

    November 1, 2010

    In caring for patients with chronic pain, I have tried all kinds of treatments to reduce bothersome symptoms, hoping to achieve improvements that are better than the usual one or two points on a visual analog scale. The list of these treatments is long—no doubt, you have tried the same ones—and include the expected array…

    Are Electronic Health Records a Plague or Panacea?

    January 17, 2011

    EHRs hold promise, but there are still plenty of kinks

    Make Critical Electronic Health Record Decisions Now to Avoid Penalties and Maximize Incentives

    January 25, 2013

    Rheumatology practices of all sizes are considering the most cost-efficient and effective ways to achieve Meaningful Use.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences